Therefore, the presence of a positive surgical margin (PSM) after radical prostatectomy (RP) for prostate cancer is considered an adverse event in curing this cancer, with outcome associated with prostate specific antigen (PSA) biochemical recurrence (BCR) and poor outcome [1, 2]. The gene discussed is KLK3; the disease is cancer.